Breaking News, Promotions & Moves

AGC Biologics CEO to Step Down

Dr. Gustavo Mahler has decided to leave his position after a 10 year tenure, and will be succeeded by Patricio Massera, current COO

AGC Biologics has announced a change in executive leadership.  Dr. Gustavo Mahler has decided to leave his position as chief executive officer effective April 30th, 2019 after a 10 year tenure with CMC Biologics and AGC Biologics. Dr. Mahler will continue on as a member of the Board of Directors. Patricio Massera, previously the chief operating officer for AGC Biologics, will succeed Dr. Mahler as the chief executive officer, effective May 1st 2019. Gustavo joined AGC Biologics (previously...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters